These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37147161)

  • 1. Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR.
    Turner V; Maret E; Kim JB; Codari M; Hinostroza V; Mastrodicasa D; Watkins AC; Fearon WF; Fischbein MP; Haddad F; Willemink MJ; Fleischmann D
    Acad Radiol; 2023 Dec; 30(12):2825-2833. PubMed ID: 37147161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CTA pulmonary artery enlargement in patients with severe aortic stenosis: Prognostic impact after TAVR.
    Turner VL; Jubran A; Kim JB; Maret E; Moneghetti KJ; Haddad F; Amsallem M; Codari M; Hinostroza V; Mastrodicasa D; Sailer AM; Kobayashi Y; Nishi T; Yeung AC; Watkins AC; Lee AM; Miller DC; Fischbein MP; Fearon WF; Willemink MJ; Fleischmann D
    J Cardiovasc Comput Tomogr; 2021; 15(5):431-440. PubMed ID: 33795188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of CT signs and measurements as a predictor of pulmonary hypertension and mortality in symptomatic severe aortic valve stenosis.
    Eberhard M; Mastalerz M; Pavicevic J; Frauenfelder T; Nietlispach F; Maisano F; Tanner FC; Nguyen-Kim TDL
    Int J Cardiovasc Imaging; 2017 Oct; 33(10):1637-1651. PubMed ID: 28550588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk stratification in patients with pulmonary hypertension undergoing transcatheter aortic valve replacement.
    Lindman BR; Zajarias A; Maniar HS; Miller DC; Suri RM; Arnold SV; Webb J; Svensson LG; Kodali S; Xu K; Ayele GM; Lin F; Wong SC; Babaliaros V; Thourani VH; Douglas PS; Lim S; Leon MB; Mack MJ
    Heart; 2015 Oct; 101(20):1656-64. PubMed ID: 26264371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Hypertension in Patients With Severe Aortic Stenosis: Prognostic Impact After Transcatheter Aortic Valve Replacement: Pulmonary Hypertension in Patients Undergoing TAVR.
    Alushi B; Beckhoff F; Leistner D; Franz M; Reinthaler M; Stähli BE; Morguet A; Figulla HR; Doenst T; Maisano F; Falk V; Landmesser U; Lauten A
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):591-601. PubMed ID: 29680341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated systolic pulmonary artery pressure is a substantial predictor of increased mortality after transcatheter aortic valve replacement in males, not in females.
    Boxhammer E; Dienhart C; Kletzer J; Ramsauer S; Kopp K; Prinz E; Wintersteller W; Blessberger H; Hammerer M; Steinwender C; Lichtenauer M; Hoppe UC
    Clin Res Cardiol; 2024 Jan; 113(1):138-155. PubMed ID: 37750991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baseline global longitudinal strain by computed tomography is associated with post transcatheter aortic valve replacement outcomes.
    Fukui M; Xu J; Thoma F; Sultan I; Mulukutla S; Elzomor H; Lee JS; Gleason TG; Cavalcante JL
    J Cardiovasc Comput Tomogr; 2020; 14(3):233-239. PubMed ID: 31836414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of pulmonary hemodynamics before transcatheter aortic valve replacement among patients with severe aortic stenosis.
    Dahiya G; Kyvernitakis A; Elhamdani A; Begg A; Doyle M; Elsayed M; Bailey S; Raina A; Kanwar M; Biederman RWW; Benza RL
    J Heart Lung Transplant; 2023 Feb; 42(2):275-282. PubMed ID: 36437170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with severe aortic stenosis and coexisting pulmonary hypertension treated by transapical transcatheter aortic valve replacement-Is there a need for increased attention?
    Keymel S; Papadopoulos G; Minol JP; Blehm A; Krüger S; Afzal S; Jung C; Westenfeld R; Lichtenberg A; Kelm M; Zeus T; Veulemans V
    Catheter Cardiovasc Interv; 2020 Apr; 95(5):1001-1008. PubMed ID: 31165581
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Pulmonary Hypertension Hemodynamic Status on Long-Term Outcome After Transcatheter Aortic Valve Replacement.
    Schewel J; Schmidt T; Kuck KH; Frerker C; Schewel D
    JACC Cardiovasc Interv; 2019 Nov; 12(21):2155-2168. PubMed ID: 31699377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Neutrophil-to-Lymphocyte Ratio on Post-TAVR Mortality and Periprocedural Pulmonary Hypertension.
    Gao X; Jiang X; Wu Z; Chen N; Gong M; Zhao X; Liu Y; Guo R
    J Interv Cardiol; 2024; 2024():4512655. PubMed ID: 38415185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baseline PA/BSA ratio in patients undergoing transcatheter aortic valve replacement - A novel CT-based marker for the prediction of pulmonary hypertension and outcome.
    Sudo M; Sugiura A; Treiling L; Al-Kassou B; Shamekhi J; Kütting D; Wilde N; Weber M; Zimmer S; Nickenig G; Sedaghat A
    Int J Cardiol; 2022 Feb; 348():26-32. PubMed ID: 34923001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Main pulmonary artery diameter in combination with cardiovascular biomarkers: new possibilities to identify pulmonary hypertension in patients with severe aortic valve stenosis.
    Boxhammer E; Paar V; Jirak P; Köller C; Demirel O; Eder S; Reiter C; Kammler J; Kellermair J; Hammerer M; Blessberger H; Steinwender C; Hoppe UC; Lichtenauer M
    Minerva Med; 2023 Dec; 114(6):802-814. PubMed ID: 35822856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of main pulmonary artery to ascending aorta diameter ratio in patients with severe aortic stenosis underwent transcatheter aortic valve implantation.
    Hakgor A; Dursun A; Kahraman BC; Yazar A; Savur U; Akhundova A; Olgun FE; Arman ME; Boztosun B
    Catheter Cardiovasc Interv; 2024 Apr; 103(5):782-791. PubMed ID: 38415894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of computed tomography derived measurements of pulmonary artery diameter for long-term outcomes after transcatheter aortic valve replacement.
    Kalińczuk Ł; Chmielak Z; Dąbrowski M; Mazurkiewicz M; Stokłosa P; Skotarczak W; Mintz GS; Wolny R; Tyczyński P; Konka M; Michałowska A; Kowalik I; Demkow M; Michałowska I; Witkowski A
    Kardiol Pol; 2022; 80(10):1020-1026. PubMed ID: 35892248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Periprocedural Pulmonary Hypertension on Outcomes After Transcatheter Aortic Valve Replacement.
    Miyamoto J; Ohno Y; Kamioka N; Ikari Y; Otsuka T; Tada N; Naganuma T; Yamawaki M; Yamanaka F; Shirai S; Mizutani K; Tabata M; Ueno H; Takagi K; Watanabe Y; Yamamoto M; Hayashida K;
    J Am Coll Cardiol; 2022 Oct; 80(17):1601-1613. PubMed ID: 36265955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The prognostic importance of the diastolic pulmonary gradient, transpulmonary gradient, and pulmonary vascular resistance in patients undergoing transcatheter aortic valve replacement.
    Brunner NW; Yue SF; Stub D; Ye J; Cheung A; Leipsic J; Lauck S; Dvir D; Perlman G; Htun N; Fahmy P; Prakash R; Eng L; Ong K; Tsang M; Cairns JA; Webb JG; Wood DA
    Catheter Cardiovasc Interv; 2017 Dec; 90(7):1185-1191. PubMed ID: 28471090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of Functional and Volumetric Left Atrial Parameters Derived From Preprocedural Cardiac CTA in Predicting Mortality After Transcatheter Aortic Valve Replacement.
    Aquino GJ; Decker JA; Schoepf UJ; Carson L; Paladugu N; Emrich AL; Yacoub B; Brandt V; Burt JR; Bayer RR; Varga-Szemes A; Emrich T
    AJR Am J Roentgenol; 2022 Mar; 218(3):444-452. PubMed ID: 34643107
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevalence and impact of pulmonary hypertension on patients with aortic stenosis who underwent transcatheter aortic valve replacement.
    Barbash IM; Escarcega RO; Minha S; Ben-Dor I; Torguson R; Goldstein SA; Wang Z; Okubagzi P; Satler LF; Pichard AD; Waksman R
    Am J Cardiol; 2015 May; 115(10):1435-42. PubMed ID: 25776456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CT measured pulmonary artery to ascending aorta ratio stratified by echocardiographically obtained systolic pulmonary artery pressure values for noninvasive detection of pulmonary hypertension in patients with severe aortic valve stenosis.
    Boxhammer E; Kletzer J; Kellermair J; Scharinger B; Kaufmann R; Hammerer M; Blessberger H; Steinwender C; Lichtenauer M; Hergan K; Hoppe UC; Hecht S
    Clin Res Cardiol; 2023 Oct; 112(10):1394-1416. PubMed ID: 36935421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.